As of 2025-07-04, the Intrinsic Value of Covetrus Inc (CVET) is 6.58 USD. This CVET valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 20.99 USD, the upside of Covetrus Inc is -68.70%.
The range of the Intrinsic Value is 2.68 - 15.74 USD
Based on its market price of 20.99 USD and our intrinsic valuation, Covetrus Inc (CVET) is overvalued by 68.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 2.68 - 15.74 | 6.58 | -68.7% |
| DCF (Growth 10y) | 5.62 - 21.97 | 10.57 | -49.6% |
| DCF (EBITDA 5y) | 11.51 - 17.91 | 14.94 | -28.8% |
| DCF (EBITDA 10y) | 11.37 - 22.73 | 16.61 | -20.9% |
| Fair Value | -0.46 - -0.46 | -0.46 | -102.21% |
| P/E | (1.92) - 2.78 | 0.35 | -98.3% |
| EV/EBITDA | 2.36 - 6.78 | 4.64 | -77.9% |
| EPV | 0.30 - 4.81 | 2.55 | -87.8% |
| DDM - Stable | (0.97) - (3.20) | (2.08) | -109.9% |
| DDM - Multi | 18.12 - 46.62 | 26.12 | 24.5% |
| Market Cap (mil) | 2,941.18 |
| Beta | 1.49 |
| Outstanding shares (mil) | 140.12 |
| Enterprise Value (mil) | 3,903.18 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.65% |
| Cost of Debt | 36.89% |
| WACC | 13.51% |